We are live on
!
Find out more
CCM
Catapult Capital Management Portfolio holdings
AUM
$265M
1-Year Est. Return
21.83%
This Fund
S&P 500
This Quarter
Est. Return
-6.98%
1 Year Est. Return
+21.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$265M
AUM Growth
-$431M
(-62%)
Cap. Flow
-$403M
Cap. Flow
% of AUM
-152.44%
Top 10 Holdings %
Top 10 Hldgs %
27.43%
Holding
286
New
68
Increased
19
Reduced
60
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$9.98M |
| 2 |
NUVA
NuVasive, Inc.
NUVA
|
+$4.39M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$3.85M |
| 4 |
Boston Scientific
BSX
|
+$3.16M |
| 5 |
Pfizer
PFE
|
+$3.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$16M |
| 2 |
AbbVie
ABBV
|
+$15.9M |
| 3 |
Zoetis
ZTS
|
+$13.5M |
| 4 |
PepsiCo
PEP
|
+$12.8M |
| 5 |
McKesson
MCK
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.36% |
| 2 | Consumer Discretionary | 7.36% |
| 3 | Industrials | 6.49% |
| 4 | Technology | 4.09% |
| 5 | Financials | 3.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
CALL
CSX Corp
CSX
$93B
| $2.69M | 1.02% |
+300,000
| New | +$2.94M |
|
|
CLVS
27
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.53M | 0.96% |
27,500
+2,500
| +10% | +$216K |
|
28
Meta Platforms (Facebook)
META
$1.37T
| $2.5M | 0.95% |
27,809
-52,071
| -65% | -$4.78M |
|
|
RDUS
29
DELISTED
Radius Health, Inc.
RDUS
| $2.5M | 0.94% |
36,000
+11,000
| +44% | +$764K |
|
|
DNKN
30
PUT
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $2.45M | 0.93% |
+50,000
| New | +$2.59M |
|
|
SHPG
31
DELISTED
Shire pic
SHPG
| $2.42M | 0.91% |
11,787
-51,468
| -81% | -$12.2M |
|
32
CALL
Brookdale Senior Living
BKD
$3.49B
| $2.3M | 0.87% |
+100,000
| New | +$2.95M |
|
|
KSU
33
CALL
DELISTED
Kansas City Southern
KSU
| $2.27M | 0.86% |
25,000
| – | – |
|
34
Pediatrix Medical
MD
$2.17B
| $2.22M | 0.84% |
28,926
+9,712
| +51% | +$784K |
|
35
Stanley Black & Decker
SWK
$14.4B
| $2.2M | 0.83% |
22,699
-1,500
| -6% | -$154K |
|
|
BEAV
36
CALL
DELISTED
B/E Aerospace Inc
BEAV
| $2.19M | 0.83% |
50,000
| – | – |
|
37
CALL
Allison Transmission
ALSN
$9.57B
| $2.13M | 0.81% |
80,000
| – | – |
|
38
CALL
Rockwell Automation
ROK
$52.4B
| $2.03M | 0.77% |
+20,000
| New | +$2.27M |
|
39
PUT
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $1.97M | 0.74% |
+60,000
| New | +$2.12M |
|
40
Molson Coors Class B
TAP
$7.79B
| $1.88M | 0.71% |
22,614
-52,670
| -70% | -$3.81M |
|
41
Signet Jewelers
SIG
$3.72B
| $1.86M | 0.7% |
13,681
-14,899
| -52% | -$1.91M |
|
42
Amgen
AMGN
$209B
| $1.79M | 0.68% |
+12,915
| New | +$2.04M |
|
|
RTN
43
DELISTED
Raytheon Company
RTN
| $1.78M | 0.67% |
+16,314
| New | +$1.7M |
|
|
AAC
44
DELISTED
AAC Holdings
AAC
| $1.78M | 0.67% |
+80,000
| New | +$2.33M |
|
|
MJN
45
CALL
DELISTED
Mead Johnson Nutrition Company
MJN
| $1.76M | 0.67% |
+25,000
| New | +$2.06M |
|
46
IQVIA
IQV
$39.1B
| $1.74M | 0.66% |
25,000
-25,000
| -50% | -$1.87M |
|
|
TWX
47
CALL
DELISTED
Time Warner Inc
TWX
| $1.72M | 0.65% |
+25,000
| New | +$1.96M |
|
48
CALL
VF Corp
VFC
$5.88B
| $1.71M | 0.64% |
+26,550
| New | +$1.82M |
|
49
Cisco
CSCO
$448B
| $1.67M | 0.63% |
63,465
+102
| +0.2% | +$2.75K |
|
50
Graphic Packaging
GPK
$3.24B
| $1.65M | 0.63% |
129,298
+55,616
| +75% | +$794K |
|
Similar funds
LOCB
AF
TCOTO
DCM
SCA
LPVHS
ATC
TFF
Catapult Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Catapult Capital Management held 286 positions worth $265M, down 62% from $696M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Catapult Capital Management withdrew a net $403M in Q3 2015, closing 135 positions and reducing 60 holdings. Its most notable exit was PepsiCo, an estimated $12.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 43% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Catapult Capital Management opened a new position in Vertex Pharmaceuticals worth $3.12M.
- Catapult Capital Management's largest Q3 2015 buy was Vertex Pharmaceuticals: 30,000 shares worth $3.12M.
- Catapult Capital Management added most to Allergan plc in Q3 2015, an estimated $9.98M increase.
- Catapult Capital Management's biggest Q3 2015 reduction was CVS Health, cutting an estimated $16M.
- Catapult Capital Management fully exited PepsiCo in Q3 2015, selling an estimated $12.8M.
- Catapult Capital Management's ten largest holdings make up 27% of its $265M portfolio in Q3 2015.
- Catapult Capital Management opened 68 new positions and closed 135 in Q3 2015.
- Catapult Capital Management's portfolio value fell 62% quarter-over-quarter to $265M.
Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.